| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Radiation Oncology [G. D. K., W. G. M., A. M., K. B.], and Department of Pathology and Laboratory Medicine [R. J. M.], University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104
Irradiation of tumor cells results in a G2 delay, which has been postulated to allow DNA repair and cell survival. The G2 delay after irradiation is marked in HeLa and other cells by delayed expression of cyclin B1. To test whether this depression of cyclin B1 contributes to the G2 delay, we induced cyclin B1 expression in irradiated HeLa cells using a dexamethasone-inducible promoter. Induction of cyclin B1 after radiation abrogated the G2 delay by approximately doubling the rate at which the cells reentered mitosis, whereas dexamethasone itself had no effect. However, overexpression of cyclin B1 did not eliminate the G2 delay in irradiated cells. In unirradiated cells, overexpression of cyclin B1 had no effect on cell cycle progression. Confirmation that reduction of cyclin B1 levels would prolong G2 was provided using antisense oligonucleotides to cyclin B1. These results demonstrate that cyclin B1 levels control the length of the G2 delay following irradiation in HeLa cells but do not exclude additional mechanisms controlling the mitotic delay after irradiation.
1 This work was supported by NIH Grants GM 47439, CA 46830, and CA 51149, and American Cancer Society Faculty Research Award (to W. G. M.), and an American Society for Therapeutic Radiology and Oncology Fellowship (to G. D. K.). The flow cytometry facility was supported by the Lucille B. Markey Trust.
2 To whom requests for reprints should be addressed, at Department of Pathology and Laboratory Medicine, John Morgan Building, Room 269, University of Pennsylvania School of Medicine, 3620 Hamilton Walk, Philadelphia, PA 19104.
Received 10/17/96. Accepted 12/20/96.
This article has been cited by other articles:
![]() |
M. Fan, K. M. Ahmed, M. C. Coleman, D. R. Spitz, and J. J. Li Nuclear Factor-{kappa}B and Manganese Superoxide Dismutase Mediate Adaptive Radioresistance in Low-Dose Irradiated Mouse Skin Epithelial Cells Cancer Res., April 1, 2007; 67(7): 3220 - 3228. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kim, K. Murphy, F. Liu, S. E. Parker, M. L. Dowling, W. Baff, and G. D. Kao Caspase-Mediated Specific Cleavage of BubR1 Is a Determinant of Mitotic Progression Mol. Cell. Biol., November 1, 2005; 25(21): 9232 - 9248. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bucci, I. D'Agnano, D. Amendola, A. Citti, G. H. Raza, R. Miceli, U. De Paula, R. Marchese, S. Albini, A. Felsani, et al. Myc Down-Regulation Sensitizes Melanoma Cells to Radiotherapy by Inhibiting MLH1 and MSH2 Mismatch Repair Proteins Clin. Cancer Res., April 1, 2005; 11(7): 2756 - 2767. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Torgler, S. Jakob, E. Ontsouka, U. Nachbur, C. Mueller, D. R. Green, and T. Brunner Regulation of Activation-induced Fas (CD95/Apo-1) Ligand Expression in T Cells by the Cyclin B1/Cdk1 Complex J. Biol. Chem., September 3, 2004; 279(36): 37334 - 37342. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Lee, M. K. Keutmann, M. L. Dowling, E. Harris, G. Chan, and G. D. Kao Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells Mol. Cancer Ther., June 1, 2004; 3(6): 661 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Kao, W. G. McKenna, M. G. Guenther, R. J. Muschel, M. A. Lazar, and T. J. Yen Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response J. Cell Biol., March 31, 2003; 160(7): 1017 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Porter, I. H. Cukier, and J. M. Lee Nuclear localization of cyclin B1 regulates DNA damage-induced apoptosis Blood, March 1, 2003; 101(5): 1928 - 1933. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, B. Shen, L. Xia, A. Khaletzkiy, D. Chu, J. Y. C. Wong, and J.-J. Li Activation of Nuclear Factor {kappa}B in Radioresistance of TP53-inactive Human Keratinocytes Cancer Res., February 1, 2002; 62(4): 1213 - 1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fletcher, Y. Cheng, and R. J. Muschel Abolishment of the Tyr-15 Inhibitory Phosphorylation Site on cdc2 Reduces the Radiation-induced G2 Delay, Revealing a Potential Checkpoint in Early Mitosis Cancer Res., January 1, 2002; 62(1): 241 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Y. Yin, L. Grove, N. S. Datta, K. Katula, M. W. Long, and E. V. Prochownik Inverse Regulation of Cyclin B1 by c-Myc and p53 and Induction of Tetraploidy by Cyclin B1 Overexpression Cancer Res., September 1, 2001; 61(17): 6487 - 6493. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Janss, A. Maity, C.-B. Tang, R. J. Muschel, W. G. McKenna, L. Sutton, and P. C. Phillips Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin Neuro-oncol, January 1, 2001; 3(1): 11 - 21. [Abstract] [PDF] |
||||
![]() |
R. J. Sleiman and B. W. Stewart Early Caspase Activation in Leukemic Cells Subject to Etoposide-induced G2-M Arrest: Evidence of Commitment to Apoptosis Rather Than Mitotic Cell Death Clin. Cancer Res., September 1, 2000; 6(9): 3756 - 3765. [Abstract] [Full Text] |
||||
![]() |
L. M. Knowles and J. A. Milner Diallyl disulfide inhibits p34cdc2 kinase activity through changes in complex formation and phosphorylation Carcinogenesis, June 1, 2000; 21(6): 1129 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Badie, J. E. Itzhaki, M. J. Sullivan, A. J. Carpenter, and A. C. G. Porter Repression of CDK1 and Other Genes with CDE and CHR Promoter Elements during DNA Damage-Induced G2/M Arrest in Human Cells Mol. Cell. Biol., April 1, 2000; 20(7): 2358 - 2366. [Abstract] [Full Text] |
||||
![]() |
T. K. MacLachlan, K. Somasundaram, M. Sgagias, Y. Shifman, R. J. Muschel, K. H. Cowan, and W. S. El-Deiry BRCA1 Effects on the Cell Cycle and the DNA Damage Response Are Linked to Altered Gene Expression J. Biol. Chem., January 28, 2000; 275(4): 2777 - 2785. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Downes, C. Bachrati, S. Devlin, M Tommasino, T. Cutts, J. Watson, I Rasko, and R. Johnson Mammalian S-phase checkpoint integrity is dependent on transformation status and purine deoxyribonucleosides J. Cell Sci., January 3, 2000; 113(6): 1089 - 1096. [Abstract] [PDF] |
||||
![]() |
G. D. Kao, W. G. McKenna, and R. J. Muschel p34Cdc2 Kinase Activity Is Excluded from the Nucleus during the Radiation-induced G2 Arrest in HeLa Cells J. Biol. Chem., December 3, 1999; 274(49): 34779 - 34784. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Taylor, S. E. DePrimo, A. Agarwal, M. L. Agarwal, A. H. Schönthal, K. S. Katula, and G. R. Stark Mechanisms of G2 Arrest in Response to Overexpression of p53 Mol. Biol. Cell, November 1, 1999; 10(11): 3607 - 3622. [Abstract] [Full Text] |
||||
![]() |
L. Yu, L. Orlandi, P. Wang, M. S. Orr, A. M. Senderowicz, E. A. Sausville, R. Silvestrini, N. Watanabe, H. Piwnica-Worms, and P. M. O'Connor UCN-01 Abrogates G2 Arrest through a Cdc2-dependent Pathway That Is Associated with Inactivation of the Wee1Hu Kinase and Activation of the Cdc25C Phosphatase J. Biol. Chem., December 11, 1998; 273(50): 33455 - 33464. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jin, S. Hardy, and D. O. Morgan Nuclear Localization of Cyclin B1 Controls Mitotic Entry After DNA Damage J. Cell Biol., May 18, 1998; 141(4): 875 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Curman, B. Cinel, D. E. Williams, N. Rundle, W. D. Block, A. A. Goodarzi, J. R. Hutchins, P. R. Clarke, B.-B. Zhou, S. P. Lees-Miller, et al. Inhibition of the G2 DNA Damage Checkpoint and of Protein Kinases Chk1 and Chk2 by the Marine Sponge Alkaloid Debromohymenialdisine J. Biol. Chem., May 18, 2001; 276(21): 17914 - 17919. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Crawford and H. Piwnica-Worms The G2 DNA Damage Checkpoint Delays Expression of Genes Encoding Mitotic Regulators J. Biol. Chem., September 28, 2001; 276(40): 37166 - 37177. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |